- Safety of Tacrolimus in Autoimmune Disease: Results From Post-marketing Surveillance in South Korea
-
Yoo WH, Lee SI, Kim TH, Sung JJ, Kim SM, Hua F, Sumarsono B, Park SH
- KMID: 2520433
- J Rheum Dis.
- 2021 Oct;28(4):202-215.
- doi: 10.4078/jrd.2021.28.4.202
Objective: Tacrolimus, a macrolide immunosuppressant, is approved in Korea for the treatment of rheumatoid arthritis (RA), lupus nephritis (LN) and myasthenia gravis (MG). We report three prospective post-marketing surveillance studies... -
- CITED
-
- Close
- SHARE
-
- Close
